Evidence map›Paper›PMID 19219662›Full record

SynthesisThe American journal on addictions

The inclusion of women and minorities in smoking cessation clinical trials: a systematic review.

Daniel L Dickerson, Robert F Leeman, Carolyn M Mazure, Stephanie S O'Malley

Abstract readSystematic Review
In one paragraph

Synthesis in The American journal on addictions. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Enhancing tobacco quitline effectiveness: identifying a superior pharmacotherapy adjuvant.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2013
    Trial
  5. Trial
  6. Representativeness of Electronic Referral to Smoking Treatment Trials in Adult Primary Care.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Under-representation of minority ethnic groups in research--call for action.The British journal of general practice : the journal of the Royal College of General Practitioners · 2013
    Article
  12. Two decades of smoking cessation treatment research on smokers with depression: 1990-2010.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2013
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Racial differences in eligibility and enrollment in a smoking cessation clinical trial.Health psychology : official journal of the Division of Health Psychology, American Psychological Association · 2011
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Daniel L DickersonIntegrated Substance Abuse Programs, University of California at Los Angeles, Los Angeles, California 90025, USA. daniel.dickerson@ucla.edu
Robert F Leeman
Carolyn M Mazure
Stephanie S O'Malley

Funding

Tobacco Dependence &Risk Factors for Treatment FailureP50AA015632 · NIAAA · YALE UNIVERSITY · PI MAKUCH, ROBERT W. · 2004 to 2008
$9.2M
Research Training Fellowship in Substance use and Addiction (RTFSA)T32DA007238 · NIDA · YALE UNIVERSITY · PI BRIAN D. KILUK, ISMENE L. PETRAKIS · 1988 to 2026
$5.7M
Improving Alcoholism TreatmentK05AA014715 · NIAAA · YALE UNIVERSITY · PI O'MALLEY, STEPHANIE S · 2004 to 2013
$2.1M
Translational Neuroscience Research in Alcoholism (TNRA-TP)T32AA015496 · NIAAA · YALE UNIVERSITY · PI PETRAKIS, ISMENE L. · 2005 to 2014
$1.6M
NIAAA NIH HHS K05 AA014715NIAAA NIH HHS K05-AA014715NIAAA NIH HHS P50 AA015632NIAAA NIH HHS P50-AA15632NIAAA NIH HHS T32 AA015496NIAAA NIH HHS T32-AA-01549602NIDA NIH HHS T32 DA007238NIDA NIH HHS T32-DA007238
6 · The paper itself

Abstract

This study assesses the impact of the 1993 NIH Revitalization Act on the inclusion and subgroup analysis of women and minorities in trials of FDA-approved smoking cessation pharmacotherapy. Female representation, while commensurate with population levels, declined significantly for trials that began recruitment after 1993(M = 47.2% vs. M = 53.9%), and fewer than half reported analyses by gender. Minorities continued to be under-represented in later trials; however, significant improvement in representation (M = 16.1% vs. M = 10%) and analysis by race occurred. Industry-sponsored studies had lower minority representation than NIH funded studies. Recommendations are offered to improve subgroup analyses and minority inclusion.

Indexed as

Patient SelectionSmoking CessationWomenClinical Trials as TopicDrug IndustryDrug TherapyFemaleHumansMaleMinority GroupsNational Institutes of Health (U.S.)United States

Identifiers

PMID19219662
PMCPMC2764011

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.